Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
NOVO Nordisk, the world's leading maker of diabetes drugs, reported a better than expected profit on Wednesday driven by new diabetes and obesity drugs, though it said sale prices would remain under pressure in the United States.
The Danish drugmaker shocked markets in